Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00627393 · OUTCOME

Donor Availability (Proportion of Scheduled Granulocyte Transfusion Days on Which Granulocytes Were Available)

Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study) · Source last updated 2015-04-17

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of available granulocyte days
Interval / dispersion
Not reported
Time frame
Measured through study completion

Analysis population: The unit of analysis is patient-days where a granulocyte transfusion was scheduled.

Groups in this outcome

Granulocyte Arm

Received G-CSF/dexamethasone-mobilized granulocyte transfusions in addition to antimicrobial therapy.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Granulocyte Arm56

Analysis denominator · Patient-days

GroupSource count
Granulocyte Arm543

Reported measurements

Source class 1
Values in percentage of available granulocyte days · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Granulocyte Arm62.62Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        62.62
denom Units Selected
Participants
denoms
  1. counts
    1. group Id
      OG000
      value
      56
    units
    Participants
  2. counts
    1. group Id
      OG000
      value
      543
    units
    Patient-days
groups
  1. description
    Received G-CSF/dexamethasone-mobilized granulocyte transfusions in addition to antimicrobial therapy.
    id
    OG000
    title
    Granulocyte Arm
param Type
NUMBER
population Description
The unit of analysis is patient-days where a granulocyte transfusion was scheduled.
reporting Status
POSTED
time Frame
Measured through study completion
title
Donor Availability (Proportion of Scheduled Granulocyte Transfusion Days on Which Granulocytes Were Available)
type
SECONDARY
type Units Analyzed
Patient-days
unit Of Measure
percentage of available granulocyte days

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice